Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 108-116

  Nada, Masatoshi ^a,b   Ohnishi, Hidenori ^a   Tochio, Hidehito ^c   Kato, Zenichiro ^a   Kimura, Takeshi ^a   Kubota, Kazuo ^a   Yamamoto, Takahiro ^a   Kamatari, Yuji O ^a   Tsutsumi, Naotaka ^c   Shirakawa, Masahiro ^c,d   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Kumiai Welfare Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Innate immunity; Mal; MyD88; TIR domain; TIRAP; TLR2

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ARTICLE; GRAM POSITIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

BINDING SITES; CELL LINE; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 84861728723     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.05.003     Document Type: Article

References (32)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics 2000, 25:187-191.
3. Bernoux M., Ve T., Williams S., Warren C., Hatters D., Valkov E., Zhang X., Ellis J.G., Kobe B., Dodds P.N. Structural and functional analysis of a plant resistance protein TIR domain reveals interfaces for self-association, signaling, and autoregulation. Cell Host Microbe 2011, 9:200-211.
4. Chan S.L., Low L.Y., Hsu S., Li S., Liu T., Santelli E., Negrate G.L., Reed J.C., Woods V.L., Pascual J. Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain. Journal of Biological Chemistry 2009, 284:21386-21392.
5. Conway D.H., Dara J., Bagashev A., Sullivan K.E. Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. Journal of Allergy and Clinical Immunology 2010, 126:172-175.
6. Delaglio F., Grzesiek S., Vuister G., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. Journal of Biomolecular NMR 1995, 6:277-293.
7. Dunne A., Ejdeback M., Ludidi P.L., O'Neill L.A.J., Gay N.J. Structural complementarity of Toll/interleukin-1 receptor domain in Toll-like receptors and the adaptors Mal and MyD88. Journal of Biological Chemistry 2003, 278:41443-41451.
8. Goddard T.D., Kneller D.G. SPARKY 3 1999, University of California, San Francisco.
9. Guan Y., Ranoa D.R.E., Jiang S., Mutha S.K., Li X., Baudry J., Tapping R.I. Human TLRs10 and 1 share common mechanisms of innate immune sensing but not signaling. Journal of Immunology 2010, 184:5094-5103.
10. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature 2002, 420:329-333.
11. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
12. Kaisho T., Akira S. Toll-like receptor function and signaling. Journal of Allergy and Clinical Immunology 2006, 117:979-987.
13. Kawai T., Akira S. Signaling to NF-κB by Toll-like receptors. Trends in Molecular Medicine 2007, 13:460-469.
14. Kenny E.F., Talbot S., Gong M., Golenbock D.T., Bryant C.E., O'Neill L.A.J. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. Journal of Immunology 2009, 183:3642-3651.
15. Khan J.A., Brint E.K., O'Neill L.A.J., Tong L. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. Journal of Biological Chemistry 2004, 279:31664-31670.
16. Khor C.C., Chapman S.J., Vannberg F.O., Dunne A., Murphy C., Ling E.Y., Frodsham A.J., Walley A.J., Kyrieleis O., Khan A., Aucan C., Segal S., Moore C.E., Knox K., Campbell S.J., Lienhardt C., Scott A., Aaby P., Sow O.Y., Grignani R.T., Sillah J., Sirugo G., Peshu N., Williams T.N., Maitland K., Davies R.J.O., Kwiatkowski D.P., Day N.P., Yala D., Crook D.W., Marsh K., Berkley J.A., O'Neill L.A.J., Hill A.V.S. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nature Genetics 2007, 39:523-528.
17. Ku C.L., von Bernuth H., Picard C., Zhang S.Y., Chang H.H., Yang K., Chrabieh M., Issekutz A.C., Cunningham C.K., Gallin J., Holland S.M., Roifman C., Ehl S., Smart J., Tang M., Barrat F.J., Levy O., McDonald D., Day-Good N.K., Miller R., Takada H., Hara T., Al-Hajjar S., Al-Ghonaium A., Speert D., Sanlavillle D., Li X., Geissmann F., Vivier E., Maródi L., Garty B.Z., Chapel H., Rodriguez-Gallego C., Bossuyt X., Abel L., Puel A., Casanova J.L. Selective predisposition to bacterial infections in IRAK-4-dedicient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. Journal of Experimental Medicine 2007, 204:2407-2422.
18. Lin S.C., Lo Y.C., Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signaling. Nature 2010, 465:885-890.
19. Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., Cunningham-Rundles C., Etzioni A., Hammartröm L., Nonoyama S., Ochs H.D., Puck J., Roifman C., Seger R., Wedgwood J. Primary immunodefiencies: 2009 update. Journal of Allergy and Clinical Immunology 2009, 124:1161-1178.
20. Nyman T., Stenmark P., Flodin S., Johansson I., Hammarstrm M., Nordlund P. The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. Journal of Biological Chemistry 2008, 283:11861-11865.
21. Ohnishi H., Tochio H., Kato Z., Orii K.E., Li A., Kimura T., Hiroaki H., Kondo N., Shirakawa M. Structual basis for the multiple interaction of the MyD88 TIR domain in TLR4 signaling. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:10260-10265.
22. Ohnishi H., Tochio H., Kato Z., Kimura T., Hiroaki H., Kondo N., Shirakawa M. 1H, 13C, and 15N resonance assignment of the TIR domain of human MyD88. Biomolecular NMR Assignments 2010, 2:123-125.
23. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nature Reviews Immunology 2007, 7:353-364.
24. Picard C., Casanova J.L., Puel A. Infectious disease in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clinical Microbiology Reviews 2011, 24:490-497.
25. Santos-Sierra S., Deshmukh S.D., Kalnitski J., Küenzi P., Wymann M.P., Golenbock D.T., Hanneke P. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO Journal 2009, 28:2018-2027.
26. Schanda P., Brutscher B. Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. Journal of the American Chemical Society 2005, 127:8014-8015.
27. Tao X., Xu Y., Zheng Y., Beg A.A., Tong L. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochemical and Biophysical Research Communications 2002, 299:216-221.
28. Tao X., Tong L. Expression, purification, and crystallization of Toll/interleukin-1 receptor (TIR) domains. Methods in Molecular Biology 2009, 517:81-88.
29. Ulrichts P., Peelman F., Beyaert R., Tavernier J. MAPPIT analysis of TLR adaptor complexes. FEBS Letters 2007, 581:629-636.
30. Valkov E., Stamp A., DiMaio F., Baker D., Verstak B., Roversi P., Kellie S., Sweet M.J., Mansell A., Gay N.J., Martin J.L., Kobe B. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14879-14884.
31. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., Chrabieh M., Mustapha I.B., Ghandil P., Camcioglu Y., Vasconcelos J., Sirvent N., Guedes M., Vitor A.B., Herrero-Mata M.J., Aróstegui J.I., Rodrigo C., Alsina L., Ruiz-Ortiz E., Juan M., Fortuny C., Yagüe J., Antón J., Pascal M., Chang H.H., Janniere L., Rose Y., Garty B.Z., Chapel H., Issekutz A., Maródi L., Rodriguez-Gallego C., Banchereau J., Abel L., Li X., Chaussabel D., Puel A., Casanova J.L. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
32. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000, 408:111-115.